KALARIS THERAPEUTICS, INC. Accumulated Other Comprehensive Income
KALARIS THERAPEUTICS, INC. (KLRS) had Accumulated Other Comprehensive Income of -$73.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$73.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$49.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $6.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $6.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$73.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$49.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $6.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-12 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-17 | -$135.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | -$134.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$139.00K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | -$138.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$62.00K 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$200.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | -$225.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | -$301.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | -$468.00K 10-K · filed 2024-03-15 | |
| 2022-09-30 | -$563.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | -$444.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$350.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | -$155.00K 10-K · filed 2023-02-15 | |
| 2021-09-30 | -$133.00K 10-Q · filed 2021-11-05 | |
| 2021-06-30 | -$25.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $13.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$112.00K 10-K · filed 2022-02-10 | |
| 2020-09-30 | -$41.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $110.00K 10-Q · filed 2020-09-02 | |
| 2019-12-31 | $68.00K 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |